This inventor holds 3 USPTO granted patents. Top assignee: Fusion Antibodies Limited. Active years: 2011-2016.
Location History:
- Belfast, IE (2011 - 2014)
- Belfast, GB (2016)
Company Filing History:
Years Active: 2011-2016
Title: Roberta Burden: Innovator in Antibody Therapy
Introduction
Roberta Burden is a prominent inventor based in Belfast, Ireland. She has made significant contributions to the field of biotechnology, particularly in the development of therapies targeting cathepsin S. With a total of 3 patents to her name, Burden's work is paving the way for innovative treatments in various medical conditions.
Latest Patents
One of Burden's latest patents focuses on a method of inhibiting chemotherapy-induced upregulation of cathepsin S on the surface of tumor cells. This method involves the administration of a cathepsin S inhibitor to these cells. Additionally, she has developed a therapy that includes an anti-cathepsin S antibody, which does not inhibit the proteolytic effect of cathepsin S but effectively inhibits angiogenesis. Another significant patent describes specific binding members, such as antibodies, that can be used in treating diseases associated with cathepsin S activity. These binding members are designed to inhibit the proteolytic activity of cathepsin S and can be applied in the treatment of various diseases, including cancer, inflammatory diseases, neurodegenerative disorders, and autoimmune disorders.
Career Highlights
Roberta Burden is currently associated with Fusion Antibodies Limited, where she continues to innovate in the field of antibody therapies. Her work has garnered attention for its potential to address critical health challenges through targeted treatments.
Collaborations
Burden collaborates with talented individuals such as Shane Olwill and Christopher Scott, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Roberta Burden's contributions to the field of biotechnology and her innovative patents highlight her role as a leading inventor in antibody therapy. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in various diseases.